Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2024-11-07 00:00:00 ET · period of report 2024-11-06 · accession 0001628280-24-046462 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-07 | 2024-11-06 | VIR | de Verneuil Vanina | EVP, GC | S - Sale | $10.11 | -4,397 | 57.0K | -7% | -$44.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-06 | S | D | 4,397 | $10.11 | 56,973 | D | — | — |